Pure Global
NCT06421753

Efficiency of Spatially Distributed Sequential Stimulation (Sdss) for Functional Electrical Stimulation (FES) of Upper Motor Neuron Syndrome (UMR) Patients

UGECAM Rhône-Alpes·ClinicalTrials.gov·device·Device trialRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Upper Motor Neuron Disease
Drug/Device/Intervention
SDSS
Study type
Interventional
Intervention type
device
Sponsor & location
Primary sponsor
UGECAM Rhône-Alpes
Location
Saint didier au mont d'or, France
Timeline & enrollment
Phase
N/A
Start date
May 14, 2024
End date
Dec 31, 2024
Enrollment
10 participants
Primary outcome

Average quadriceps power output (watts) measured during 3 minutes of FES cycling

Summary

To determine whether Spatially Distributed Sequential Functional Electrical Stimulation is
 more effective than Standard Electrical Stimulation During Functional Electrical Stimulation
 in Upper Motor Neuron Patients

ICD-10 classifications
Motor neuron diseaseUpper motor neuron facial paralysisOther mononeuropathies of upper limbMononeuropathies of upper limbMononeuropathy of upper limb, unspecified
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06421753
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT06421753 through Pure Global AI's free database. This phase not specified trial is sponsored by UGECAM Rhône-Alpes and is currently Recruiting. The study focuses on Upper Motor Neuron Disease. Target enrollment is 10 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.